News
NEO
16.83
-0.77%
-0.13
Weekly Report: what happened at NEO last week (1102-1106)?
Weekly Report · 2d ago
NeoGenomics (NEO) Cut Its Losses In Q3, Is The 26% Undervaluation Case Convincing?
Simply Wall St · 3d ago
What NeoGenomics Stock's Narrower Loss Means For Shareholders
Simply Wall St · 4d ago
NeoGenomics to Participate in Upcoming Investor Conferences
Barchart · 5d ago
Missed NeoGenomics' Rally? Here Is What Holders Saw
Simply Wall St · 6d ago
Weekly Report: what happened at NEO last week (1026-1030)?
Weekly Report · 11/02 10:12
NeoGenomics (NEO) Could Be 24% Below Fair Value As Losses Narrow in Q3
Simply Wall St · 11/01 07:27
What NeoGenomics (NEO)'s Raised Guidance Means For Shareholders
Simply Wall St · 10/31 03:41
NeoGenomics (NEO) Q3 Results Show Margin Gains Beneath A Flat Stock Price
Simply Wall St · 10/30 00:32
Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Iovance Biotherapeutics (IOVA) and NeoGenomics (NEO)
TipRanks · 10/29 19:10
NeoGenomics Is Maintained at Buy by TD Cowen
Dow Jones · 10/29 17:37
NeoGenomics Price Target Raised to $23.00/Share From $19.00 by TD Cowen
Dow Jones · 10/29 17:37
TD Cowen Maintains Buy on NeoGenomics, Raises Price Target to $23
Benzinga · 10/29 17:27
NeoGenomics price target raised to $23 from $19 at TD Cowen
TipRanks · 10/29 13:17
NeoGenomics price target raised to $21 from $16.50 at Jefferies
TipRanks · 10/29 12:55
What NeoGenomics Holders Bought Into Before A 75% Run
Simply Wall St · 10/29 12:44
Needham Keeps Their Buy Rating on NeoGenomics (NEO)
TipRanks · 10/29 12:13
Analysts Are Bullish on Top Healthcare Stocks: NeoGenomics (NEO), Align Tech (ALGN)
TipRanks · 10/29 11:30
NeoGenomics (NEO) Q3 2026 Earnings Call Transcript
The Motley Fool · 10/29 04:13
NeoGenomics, Inc. Reports Third Quarter 2026 Total Revenue of $209 million
NASDAQ · 10/29 00:31
More
Webull provides a variety of real-time NEO stock news. You can receive the latest news about Neogenomics Inc through multiple platforms. This information may help you make smarter investment decisions.
About NEO
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing, interpretation and consultative services, molecular and NGS testing, comprehensive technical and professional services offering, clinical trials and research, validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Molecular testing and others.